Curidium Joins Personalized Medicine Coalition | GenomeWeb
NEW YORK (GenomeWeb News) - Curidium Medica said today that it has joined the Personalized Medicine Coalition, a US-based non-profit that aims to advance personalized medicine concepts and products.
 
The PMC is composed of pharmaceutical, biotechnology, diagnostics, and information technology companies.
 
Curidium is a UK-based developer of blood-based diagnostics for disorders of the central nervous system.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.